A program run through the Charles Sturt University (CSU) Speech Pathology Service in Albury-Wodonga will give adults who stutter greater access to an intensive treatment close to home.The week-long program from Monday 12 September is targeted at the one per cent of adult speakers who stutter.Speech pathology lecturer at CSU's School of Community Health, Dr Lisa Brown said intensive programs can have a significant impact on speech in a short period of time."The intensive format enables in-depth speech training, practice and mastery of techniques used to speak without stuttering," said Dr Brown."People can typically achieve stutter-free speech by the end of the third or fourth day of treatment, and use the rest of the week to practice speaking without stuttering in a variety of situations to boost their confidence using the techniques."Intensive treatments are not typically offered by public health services and can be very costly when offered through private speech pathology services."Charles Sturt University is the only university providing intensive treatment in a regional setting."Dr Brown recently completed her PhD on stuttering treatment methods. Read more here.The program will be delivered by final-year Bachelor of Speech and Language Pathology students, supervised by Dr Brown."Delivering intensive stuttering treatment provides students with significant experience working with adults who stutter within a short period of time," said Dr Brown."Many of our graduates will go on to work in regional and rural areas, away from specialist metropolitan services and this will help them to better serve adults who stutter wherever they go."The program will run from Monday 12 September to Friday 16 September with an initial assessment before the treatment and two follow up sessions.Bookings are essential and the cost is $300. Contact the CSU Community Engagement and Wellness Centre on (02) 6051 9299.While the program is aimed at adults, adolescents aged between 15 and 18 years can also contact Dr Brown to discuss their suitability for this treatment.